Thursday, July 11, 2024

Type 2 diabetes treatment found to impact fungal community in human gut

From left are graduate student Sophia Kenney and postdoctoral scholar Emily Van Syoc with Erika Ganda, assistant professor of food animal microbiomes. Credit: Pennsylvania State University Metabolic diseases, such as type 2 diabetes, are associated with compositional shifts in the human gut microbiome, including the fungal fraction called the mycobiome. But research on the mycobiome and how type 2 diabetes or its common treatment, metformin, may interact remains relatively limited despite suggestions that these fungi can influence the overall health of the microbiome, according to a research team at Penn Read More

No comments:

Post a Comment